arrow
A

Abraham J. Wu

Memorial Sloan Kettering Cancer Center
H指数:46
被引数:9,339
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial

不可切除的III期非小细胞肺癌中,Canakinumab联合化放疗和Durvalumab巩固治疗:CHORUS I/II期试验

2026-09-070
OAAI
Clinical implementation of automated IMRT/VMAT planning for lung cancer radiation therapy using the expedited constrained hierarchical optimization (ECHO) system

利用加速约束层次优化(ECHO)系统实现肺癌放疗中自动化IMRT/VMAT计划的临床应用

2026-07-010
PRE
Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapy

KRAS G12C抑制剂的联合胸部放射治疗安全性特征

2026-03-310
PRE
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma

肿瘤信息指导的循环肿瘤DNA对肛管鳞状细胞癌的复发风险和生存期进行分层。

2026-02-260
OAAI
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Non-Squamous Non-Small Cell Lung Cancer Treated with Chemoradiation and Immunotherapy

KRAS突变和共同改变对化疗和免疫治疗的III期非鳞状非小细胞肺癌预后的影响

2026-01-290
PRE
Prospective validation of a pretreatment 18F-FDG PET/CT and mean lung dose model for early radiation pneumonitis

前瞻性验证一种治疗前18F-FDG PET/CT和平均肺剂量模型用于早期放射性肺炎

2025-09-270
OAAI
Development of Second Malignancies Following Chemotherapy with or without Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer

局部晚期直肠癌治疗中,化疗联合或不联合放疗后第二恶性肿瘤的发展

2025-07-190
PRE
“Hope" Drives Quality of Life in Patients with Brain Metastases, But, the "Hope Center" Remains Elusive: An Analysis of NRG-CC003

“希望”驱动脑转移瘤患者的生活质量,但,“希望中枢”仍难以捉摸:NRG-CC003分析

2025-07-020
PRE
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy

技术上可切除的胰腺癌采用消融放射治疗的非手术治疗管理

2025-04-101
PRE
Clinical Outcomes, Patterns of Failure, and Salvage Therapies of a Large Modern Cohort of Patients With Anal Squamous Cell Carcinoma Treated With Definitive-Intent Intensity- Modulated Radiation Therapy
2025-03-010
PRE
Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

接受全直肠系膜切除术或选择性观察等待策略治疗的总新辅助治疗患者的生存情况:CAO/ARO/AIO-12和OPRA随机II期试验的合并分析

2025-01-012
PRE
Esophagectomy may have a role in stage IV esophageal adenocarcinoma

食管切除术可能在IV期食管腺癌中发挥作用。

2024-11-220
PRE
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
2024-11-011
PRE
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials

放化疗加诱导或巩固化疗作为局部晚期直肠癌的总新辅助治疗: CAO/ARO/AIO-12和OPRA随机2期试验的汇总分析

2024-10-010
PRE
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial
2024-07-012
PRE